Needham has upgraded Boston Scientific to a Buy, setting a new $113 target based on strengthened growth potential and less ...

Boston was the scene of many “firsts” for the United States. From the first newspaper in the Thirteen Colonies to discovering ...

Boston Scientific Corp. closed 11.12% below its 52-week high of $107.17, which the company reached on February 5th.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

Fintel reports that on April 16, 2025, Needham upgraded their outlook for Boston Scientific (NYSE:BSX) from Hold to Buy. Analyst Price Forecast Suggests 27.04% Upside As of April 2, 2025, the average ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $118.54, a high ...

Needham upgraded Boston Scientific (BSX) to Buy from Hold with a $113 price target Needham’s latest electrophysiologist survey shows the ...

Needham upgraded Boston Scientific (BSX) to Buy from Hold with a $113 price target Stay Ahead of the Market: Discover outperforming stocks and ...